nanotechnology « Science and Enterprise

The Food and Drug Administration has authorized a clinical trial of stem cells extracted and cultured from patients… https://t.co/68QuQj2ik5
about 9 hours ago
New post on Science and Enterprise: FDA Clears Stem Cell Trial for Multiple Sclerosis https://t.co/iLohWcDKEC #Science #Business
about 9 hours ago
A venture philanthropy group is funding an initiative to find digital data indicators of early onset of Alzheimer's… https://t.co/YBoAZKBjBw
about 1 day ago
New post on Science and Enterprise: Alzheimer’s Digital Biomarkers Project Gains New Funds https://t.co/lxhfwd4Bzi #Science #Business
about 1 day ago
Shionogi starts clinical test on oral COVID drug | NHK WORLD-JAPAN News https://t.co/EAQvk9nGjw
about 2 days ago

Patent Awarded for Safer Cancer Drug Delivery

By Alan, on June 18th, 2021%

A pharmaceutical R&D company is receiving a patent for its process that encapsulates and better targets chemotherapy drugs for cancer patients. . . . → Read More: Patent Awarded for Safer Cancer Drug Delivery

Flexible Electrodes Devised for Implanted Devices

By Alan, on June 17th, 2021%

Biomedical engineers designed flexible electrodes that in lab tests safely connect and deliver electrical current to animal hearts and brains. . . . → Read More: Flexible Electrodes Devised for Implanted Devices

Plant-Based Lipids Developed for mRNA Vaccines

By Alan, on May 28th, 2021%

Chemists at industry and academic labs created safer lipids for delivering messenger RNA vaccines, such as those protecting against Covid-19. . . . → Read More: Plant-Based Lipids Developed for mRNA Vaccines

Start-Up Designing Synthetic DNA for Gene Therapies

By Alan, on April 20th, 2021%

A new biotechnology company is underway creating gene therapies for inherited diseases delivered with synthetic DNA instead of benign viruses. . . . → Read More: Start-Up Designing Synthetic DNA for Gene Therapies

Novavax Joins Alternative Second Shot Vaccine Trial

By Alan, on April 15th, 2021%

Vaccine developer Novavax is taking part in a clinical trial testing effects of different Covid-19 vaccines in first and second immunizations. . . . → Read More: Novavax Joins Alternative Second Shot Vaccine Trial

Infectious Disease Biotech Raises $100M in Venture Funds

By Alan, on April 7th, 2021%

A biotechnology company designing vaccines for viral diseases including Covid-19 is raising $100 million in its second venture funding round. . . . → Read More: Infectious Disease Biotech Raises $100M in Venture Funds

In-Body Gene Editing Tested as Sickle Cell Treatment

By Alan, on March 11th, 2021%

Tests with lab mice show the feasibility of editing genes in blood-forming stem cells in bone marrow as a potential treatment for sickle cell disease. . . . → Read More: In-Body Gene Editing Tested as Sickle Cell Treatment

Sensor in Works Detecting Covid-19 Airborne Virus

By Alan, on March 3rd, 2021%

A company developing graphene bio-computer chips is applying its technology to sensors that quickly detect SARS-CoV-2 viruses in indoor air. . . . → Read More: Sensor in Works Detecting Covid-19 Airborne Virus

Novavax, J&J Return Mixed Covid-19 Vaccine Results

By Alan, on January 29th, 2021%

Results from international clinical trials show largely favorable results for two Covid-19 vaccines, but still limitations against the South African variant. . . . → Read More: Novavax, J&J Return Mixed Covid-19 Vaccine Results

Simpler Method Devised to Validate Covid-19 Tests

By Alan, on December 2nd, 2020%

An engineering lab created simple and stable control probes to validate widely used diagnostic tests for SARS-Cov-2 viruses responsible for Covid-19. . . . → Read More: Simpler Method Devised to Validate Covid-19 Tests

Subscribe for email alerts

Specials

Follow us on Twitter

Guest Posts

Please share Science & Enterprise

Posts RSS feed